Preclinical studies in mouse models have also demonstrated that loss of HIF-1α or HIF-2α expression impairs the metastasis of breast cancer cells to axillary lymph nodes [10], lungs [11,12] and bone [13,14]. This evidence concerns the gene HIF1A and breast cancer.